EUVIMEDEUVIMED entdecken
Open Access

Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema

Gamze Karataş iD, Akın Çakır iD, Öznur Aday iD, Tahsin Uzundede iD, Furkan Kırık iD, Ahmet Melih Özoğuz iD, Hakan Özdemir iD, Mustafa Nuri Elçioğlu iD

Turkish Journal of Ophthalmology · 2026

DOI: 10.4274/tjo.galenos.2025.77246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Ophthalmology, 2026. Verfasst von Gamze Karataş und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences Türkiye, İstanbul Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinic of Ophthalmology, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Dexamethasone, Macular Edema, Diabetic Retinopathy, Visual Acuity. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To demonstrate the efficacy and safety of repeated dexamethasone (DEX) implants in eyes with naïve diabetic macular edema (DME) using real-life data over a minimum of 36 months follow-up. Materials and Methods: This retrospective cohort study included treatment-naïve DME patients treated with intravitreal DEX monotherapy and followed for at least 36 months. Main outcomes were best corrected visual acuity (BCVA) and central macular thickness (CMT) change. Secondary outcomes were optical coherence tomography findings, including serous macular detachment, hard exudate, hyperreflective foci, cystoid degeneration, pearl necklace sign, epiretinal membrane (ERM), disorganization of the retinal inner layers (DRIL), ellipsoid zone and external limiting membrane (EZ-ELM) integrity, and intra-cystic hyperreflective material, as well as intraocular pressures and lens status.

Results

The study included 74 eyes of 52 patients. The mean follow-up period and number of injections were 49.24±13.51 months and 6.83±2.76, respectively. Both BCVA and CMT improved significantly throughout follow-up (p=0.009; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneMacular EdemaDiabetic RetinopathyVisual AcuityHumansRetrospective StudiesFemaleDrug ImplantsMaleGlucocorticoidsTomography, Optical CoherenceIntravitreal InjectionsFollow-Up StudiesMiddle AgedTreatment OutcomeTime FactorsAged

Stichwörter der Autor:innen

Dexamethasonediabetic macular edemadiabetic retinopathysteroid

Substanzen

DexamethasoneDrug ImplantsGlucocorticoids

Autor:innen und Institutionen

  • University of Health Sciences Türkiye, İstanbul Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinic of Ophthalmology, İstanbul, Türkiye.
  • Bezmialem Vakıf University Faculty of Medicine, Department of Ophthalmology, İstanbul, Türkiye.

ORCID-Profile: Gamze Karataş, Akın Çakır, Öznur Aday, Tahsin Uzundede, Furkan Kırık, Ahmet Melih Özoğuz, Hakan Özdemir, Mustafa Nuri Elçioğlu

Zitieren

APA

Karataş, G., Çakır, A., Aday, Ö., Uzundede, T., Kırık, F., Özoğuz, A. M., Özdemir, H., & Elçioğlu, M. N. (2026). Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema. Turkish Journal of Ophthalmology. https://doi.org/10.4274/tjo.galenos.2025.77246

Vancouver

Karataş G, Çakır A, Aday Ö, Uzundede T, Kırık F, Özoğuz AM, et al. Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema. Turkish Journal of Ophthalmology. 2026. doi:10.4274/tjo.galenos.2025.77246

BibTeX
@article{Karata2026,
  author = {Karataş, Gamze and Çakır, Akın and Aday, Öznur and Uzundede, Tahsin and Kırık, Furkan and Özoğuz, Ahmet Melih and Özdemir, Hakan and Elçioğlu, Mustafa Nuri},
  title = {Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema},
  journal = {Turkish Journal of Ophthalmology},
  year = {2026},
  doi = {10.4274/tjo.galenos.2025.77246}
}
Kostenlos starten →